Evidence map›Paper›PMID 40771706›Full record

ArticleJournal of food allergy2024

Infant anaphylaxis and epinephrine use: Can we improve acute management?

Aikaterini Anagnostou, Matthew Greenhawt, S Shahzad Mustafa, Jay A Lieberman, Marcus Shaker

Abstract read
In one paragraph

Article in Journal of food allergy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aikaterini AnagnostouFrom the Division of Allergy and Immunology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
Matthew GreenhawtSection of Allergy and Clinical Immunology, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado.
S Shahzad MustafaDivision of Allergy, Immunology, and Rheumatology, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York.
Jay A LiebermanDepartment of Pediatrics, The University of Tennessee Health Sciences Center, Memphis, Tennessee.
Marcus ShakerDepartments of Medicine and Pediatrics, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire; and.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Anaphylaxis is a serious systemic hypersensitivity reaction that is rapid in onset and may cause death. Methods: The true prevalence of infant anaphylaxis is unknown, but such cases may be increasing in presentation of these patients to emergency departments, with studies that evaluate health-care utilization after implementation of early introduction guidelines that report an increase in the use of emergency department for food-related visits as well as an increase in epinephrine prescriptions for infants. Results: Reasons for these increases may include early food introduction as well as therapeutic interventions such as early life or preschool oral immunotherapy. Conclusion: Infant anaphylaxis presents many diagnostic challenges, including poor recognition attributable to confusing signs and symptoms that may be age specific, and risk for inadequate acute management.

Indexed as

anaphylaxisauto-injectoreducationepinephrineinfant

Identifiers

PMID40771706
PMCPMC12322901

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.